• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    ICL Reports Second Quarter 2025 Results

    8/6/25 2:06:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials
    Get the next $ICL alert in real time by email

    Sales of $1.8 billion increased year-over-year, with operating income of $181 million, adjusted EBITDA of $351 million and adjusted diluted EPS of $0.09

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2025. Consolidated sales were $1.8 billion, up ~$80 million versus the prior year. Operating income was $181 million versus $211 million of operating income in the second quarter of last year, with adjusted operating income of $201 million versus $225 million. For the second quarter, net income attributable to shareholders was $93 million versus $115 million in the prior year, with adjusted net income of $110 million compared to $126 million. Adjusted EBITDA was $351 million versus $377 million. Diluted earnings per share were $0.07 versus $0.09 in the second quarter of last year, with adjusted diluted EPS of $0.09 versus $0.10.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250805898603/en/

    "For the second quarter, ICL delivered both a year-over-year and sequential increase in sales, against a backdrop of generally positive trends in most markets. Results were once again led by our specialties-driven businesses. Combined, our Industrial Products, Phosphate Solutions and Growing Solutions businesses reported year-over-year growth in sales for both the second quarter and first half of the year. For our Potash segment, second quarter sales were lower versus the prior year, due to lower quantities and as we continued to supply potash to India and China at 2024 contract prices. We expect sales for the Potash segment to improve in the third quarter, due to an increase in the prices for both the 2025 contracts with India and China and for spot transactions," said Elad Aharonson, president and CEO of ICL. "For the most part, second quarter trends were a continuation of the first quarter and in-line with expectations. Looking toward the second half of the year, we expect to gradually benefit from price improvement and to continue to focus on our regional-specific specialties-driven businesses."

    The company reiterated its guidance for specialties-driven EBITDA of between $0.95 billion to $1.15 billion for full year 2025. For Potash, ongoing geopolitical unrest – and a brief period of regional conflict – impacted production in Israel. For 2025, the company now expects sales volumes of between 4.3 million and 4.5 million metric tons. (1a)

    Key Financials

    Second Quarter 2025

    US$M

    Ex. per share data

    2Q'25

    2Q'24

    Sales

    $1,832

    $1,752

    Gross profit

    $554

    $568

    Gross margin

    30%

    32%

    Operating income

    $181

    $211

    Adjusted operating income (1)

    $201

    $225

    Operating margin

    10%

    12%

    Adjusted operating margin (1)

    11%

    13%

    Net income attributable to shareholders

    $93

    $115

    Adjusted net income attributable to shareholders (1)

    $110

    $126

    Adjusted EBITDA (1)

    $351

    $377

    Adjusted EBITDA margin (1)

    19%

    22%

    Diluted earnings per share

    $0.07

    $0.09

    Diluted adjusted earnings per share (1)

    $0.09

    $0.10

    Cash flows from operating activities (2)

    $269

    $316

    (1)

    Adjusted operating income and margin, adjusted net income attributable to shareholders, adjusted EBITDA and margin, and diluted adjusted earnings per share are non-GAAP financial measures. Please refer to the adjustments table and disclaimer.

    (2)

    See "Condensed consolidated statements of cash flows (unaudited)" in the appendix below.

    Industrial Products

    Second quarter 2025

    • Sales of $319 million vs. $315 million.
    • EBITDA of $69 million vs. $74 million.
    • Stable performance was in-line with first quarter trends and market expectations.

    Key developments versus prior year

    • Flame retardants: Overall sales decreased slightly, as bromine-based product sales decreased, with higher prices unable to offset lower volumes and as the construction end-market remained soft. Sales of phosphorous-based solutions increased, as higher volumes and prices followed the implementation of duties on Chinese imports – especially in the United States.
    • Elemental bromine: Sales decreased slightly year-over-year, as lower volumes were only partially offset by higher prices.
    • Clear brine fluids: Sales increased, primarily due to higher volumes, mainly in the United States.
    • Specialty minerals: Stable sales reflected steady end-market demand and were in-line with the prior year.

    Potash

    Second quarter 2025

    • Sales of $383 million vs. $422 million.
    • EBITDA of $115 million vs. $118 million.
    • Grain Price Index decreased 17.2% year-over-year, with corn up 2.3%, while rice, soybeans and wheat were down 27.0%, 11.8% and 18.4%, respectively. On a sequential basis, the Index declined 3.3%, with corn, rice and wheat down 2.0%, 4.6% and 6.5%, respectively, while soybeans increased 3.3%.

    Key developments versus prior year

    • Potash price: $333 per ton (CIF).
      • Up 11% both sequentially and year-over-year.
    • Potash agreements
      • ICL continued to fulfill its 2024 annual contracts with China and India, and the prices in these agreements were lower than market rates, which improved as the second quarter progressed.
      • In June, ICL reached an agreement with IPL in India, to supply an aggregate of 400,000 metric tons of potash at $349 per metric ton – in-line with current market prices in India.
      • Also in June, ICL signed contracts with its Chinese customers to supply 750,000 metric tons of potash at $346 per metric ton, which aligns with recent contract settlements in China.
    • Potash sales volumes: 971 thousand metric tons.
    • Completed annual maintenance shutdown in Israel.
    • Decreased by 182 thousand metric tons, with lower volumes mainly to China but an increase in volumes to Europe.
    • ICL Dead Sea
    • Production decreased, due to operational challenges primarily related to ongoing war related issues, the annual maintenance shutdown, and a brief period of regional unrest in June.
    • ICL Iberia
      • Production was in-line with the prior year but up sequentially, as efficiency efforts remain on track.

    Phosphate Solutions

    Second quarter 2025

    • Sales of $637 million vs. $572 million.
    • EBITDA of $134 million vs. $146 million.
    • Year-over-year and sequential growth in sales driven by strength in commodities, while specialties results were lower but in-line with market dynamics.

    Key developments versus prior year

    • White phosphoric acid: Sales increased slightly, as volume growth in all major regions offset lower prices.
    • Industrial phosphates: Sales increased, as higher volumes – particularly in North America and China – offset lower prices.
    • Food phosphates: Despite higher volumes, sales were flat due to lower market prices, however, products for both dairy- and plant-protein markets continued to see good growth.
    • Battery materials: Sales increased in China year-over-year, reflecting both higher volumes and prices, as the market continued to grow.
    • Commodity phosphates: Overall phosphate prices strengthened significantly during the quarter, supported by favorable weather conditions across most key markets and as China continued to restrict exports.

    Growing Solutions

    Second quarter 2025

    • Sales of $540 million vs. $494 million.
    • EBITDA of $56 million vs. $45 million.
    • Year-over-year growth driven by continued focus on innovative, regional solutions.

    Key developments versus prior year

    • Brazil: Sales increased, as higher prices offset lower volumes, while exchange rate fluctuations impacted gross profit.
    • Europe: Sales increased, with higher prices offsetting lower volumes, while gross profit increased, due to improved mix, including higher sales of specialty agriculture products.
    • North America: Sales increased, due to higher volumes, favorable pricing and the July 2024 acquisition of Custom Ag Formulators, with improved gross profit across the region, despite ongoing tariff-related issues and a challenging ag economy.
    • Asia: Sales in-line with the prior year, with improved product mix – including an increase in sales of specialty ag products – contributing to higher gross profit.
    • Product trends: Specialty agriculture sales increased, with higher volumes in most major regions and higher prices in Europe and for micronutrients in Brazil. Turf and ornamental sales increased, with turf and landscape experiencing higher volumes, while higher prices for ornamental horticulture offset lower volumes.

    Financial Items

    Financing Expenses

    Net financing expenses for the second quarter of 2025 were $13 million, down versus $33 million in the corresponding quarter of last year, with the decrease primarily due to exchange rate differences net of hedging transactions.

    Tax Expenses

    Reported tax expenses in the second quarter of 2025 were $60 million, reflecting an effective tax rate of 36%, compared to $48 million in the corresponding quarter of last year, reflecting an effective tax rate of 27%. The relatively higher effective tax rate in the quarter was primarily due to the appreciation of the Israeli shekel versus the U.S. dollar. For the first half of the year, the reported effective tax rate was ~32%.

    Available Liquidity

    ICL's available cash resources, which are comprised of cash and deposits, unutilized revolving credit facility, and unutilized securitization, totaled $1,466 million, as of June 30, 2025.

    Outstanding Net Debt

    As of June 30, 2025, ICL's net financial liabilities amounted to $2,214 million, an increase of $363 million compared to December 31, 2024.

    Dividend Distribution

    In connection with ICL's second quarter 2025 results, the Board of Directors declared a dividend of 4.26 cents per share, or approximately $55 million, versus 4.88 cents per share, or approximately $63 million, in the second quarter of last year. The dividend will be payable on September 17, 2025, to shareholders of record as of September 3, 2025.

    About ICL

    ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2024 revenue totaled approximately $7 billion.

    For more information, visit ICL's website at icl-group.com.

    To access ICL's interactive CSR report, visit icl-group-sustainability.com.

    You can also learn more about ICL on Facebook, LinkedIn, YouTube, X and Instagram.

    Guidance

    (1a) The company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. The company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The company provides guidance for specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions. For the Potash business, the company is providing sales volume guidance.

    Non-GAAP Statement

    The company discloses in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Management uses adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. The company calculates adjusted operating income by adjusting operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below. Certain of these items may recur. The company calculates adjusted net income attributable to the company's shareholders by adjusting net income attributable to the company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below, excluding the total tax impact of such adjustments. The company calculates diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under "Consolidated adjusted EBITDA, and diluted adjusted earnings per share for the periods of activity" below, which were adjusted for in calculating the adjusted operating income.

    You should not view adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the company's shareholders determined in accordance with IFRS, and you should note that the company's definitions of adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of the company's non-IFRS financial measures as tools for comparison. However, the company believes adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of ongoing operations. Management uses these non-IFRS measures to evaluate the company's business strategies and management performance. The company believes these non‑IFRS measures provide useful information to investors because they improve the comparability of financial results between periods and provide for greater transparency of key measures used to evaluate performance.

    The company presents a discussion in the period-to-period comparisons of the primary drivers of change in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on the company's businesses. The company has based the following discussion on its financial statements. You should read such discussion together with the company's financial statements.

    Forward-looking Statements

    This announcement contains statements that constitute "forward‑looking statements", many of which can be identified by the use of forward‑looking words such as "anticipate", "believe", "could", "expect", "should", "plan", "intend", "estimate", "strive", "forecast", "targets" and "potential", among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements.

    Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding the company intent, belief or current expectations. Forward‑looking statements are based on the company management's beliefs and assumptions and on information currently available to the company management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:

    Changes in exchange rates or prices compared to those we are currently experiencing; the effects of the ongoing security situation in Israel, including the nature and duration of related conflicts; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and the company reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at the company seaport shipping facilities or regulatory restrictions affecting the company ability to export the company products overseas; general market, political or economic conditions in the countries in which the company operates, including tariffs and trade policies; price increases or shortages with respect to the company principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the company plants; labor disputes, slowdowns and strikes involving the company employees; pension and health insurance liabilities; disruptions from pandemics that may impact the company sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in the company evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of the company, or the company service providers', information technology systems or breaches of the company, or the company service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the company cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the company businesses; changes in demand for the company fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company control; sales of the company magnesium products being affected by various factors that are not within the company control; the company ability to secure approvals and permits from the authorities in Israel to continue the company phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the company workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of war declared in Israel and any resulting disruptions to the company supply and production chains; filing of class actions and derivative actions against the company, its executives and Board members; the company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the company's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the "SEC") on March 13, 2025 (the "Annual Report").

    Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risks and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements.

    This announcement for the second quarter of 2025 (the "Quarterly Report") should be read in conjunction with the Annual Report of 2024 as of and for the year ended December 31, 2024 published by the company on Form 20-F and the published report for the first quarter of 2025 (the "prior quarterly report"), including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the US SEC.

    Appendix

    Condensed Consolidated Statements of Income (Unaudited)

     

    $ millions

    Three-months ended

    Six-months ended

    Year ended

     

    June 30,

    2025

    June 30,

    2024

    June 30,

    2025

    June 30,

    2024

    December 31, 2024

    Sales

    1,832

     

    1,752

     

    3,599

     

    3,487

     

    6,841

     

    Cost of sales

    1,278

     

    1,184

     

    2,485

     

    2,362

     

    4,585

     

     

     

     

     

     

     

    Gross profit

    554

     

    568

     

    1,114

     

    1,125

     

    2,256

     

     

     

     

     

     

     

    Selling, transport and marketing expenses

    274

     

    280

     

    542

     

    553

     

    1,114

     

    General and administrative expenses

    72

     

    64

     

    149

     

    128

     

    259

     

    Research and development expenses

    19

     

    14

     

    37

     

    31

     

    69

     

    Other expenses

    11

     

    2

     

    27

     

    5

     

    60

     

    Other income

    (3

    )

    (3

    )

    (7

    )

    (6

    )

    (21

    )

     

     

     

     

     

     

    Operating income

    181

     

    211

     

    366

     

    414

     

    775

     

     

     

     

     

     

     

    Finance expenses

    98

     

    59

     

    160

     

    119

     

    181

     

    Finance income

    (85

    )

    (26

    )

    (110

    )

    (51

    )

    (41

    )

    Finance expenses, net

    13

     

    33

     

    50

     

    68

     

    140

     

     

     

     

     

     

     

    Share in earnings of equity-accounted investees

    -

     

    -

     

    -

     

    -

     

    1

     

     

     

     

     

     

     

    Income before taxes on income

    168

     

    178

     

    316

     

    346

     

    636

     

     

     

     

     

     

     

    Taxes on income

    60

     

    48

     

    102

     

    90

     

    172

     

     

     

     

     

     

     

    Net income

    108

     

    130

     

    214

     

    256

     

    464

     

     

     

     

     

     

     

    Net income attributable to the non-controlling interests

    15

     

    15

     

    30

     

    32

     

    57

     

     

     

     

     

     

     

    Net income attributable to the shareholders of the Company

    93

     

    115

     

    184

     

    224

     

    407

     

     

     

     

     

     

     

    Earnings per share attributable to the shareholders of the Company:

     

     

     

     

     

     

     

     

     

     

     

    Basic earnings per share (in dollars)

    0.07

     

    0.09

     

    0.14

     

    0.17

     

    0.32

     

     

     

     

     

     

     

    Diluted earnings per share (in dollars)

    0.07

     

    0.09

     

    0.14

     

    0.17

     

    0.32

     

     

     

     

     

     

     

    Weighted-average number of ordinary shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

    Basic (in thousands)

    1,290,751

     

    1,289,901

     

    1,290,603

     

    1,289,716

     

    1,289,968

     

     

     

     

     

     

     

    Diluted (in thousands)

    1,292,096

     

    1,290,158

     

    1,291,450

     

    1,289,977

     

    1,290,039

     

    Condensed Consolidated Statements of Financial Position as of (Unaudited)

     

    $ millions

    June 30,

    2025

    June 30,

    2024

    December 31,

    2024

    Current assets

     

     

     

    Cash and cash equivalents

    582

    287

    327

    Short-term investments and deposits

    119

    109

    115

    Trade receivables

    1,431

    1,429

    1,260

    Inventories

    1,690

    1,544

    1,626

    Prepaid expenses and other receivables

    413

    298

    258

    Total current assets

    4,235

    3,667

    3,586

     

     

     

     

    Non-current assets

     

     

     

    Deferred tax assets

    172

    147

    143

    Property, plant and equipment

    6,701

    6,285

    6,462

    Intangible assets

    941

    857

    869

    Other non-current assets

    326

    249

    261

    Total non-current assets

    8,140

    7,538

    7,735

     

     

     

     

    Total assets

    12,375

    11,205

    11,321

     

     

     

     

    Current liabilities

     

     

     

    Short-term debt

    365

    577

    384

    Trade payables

    1,082

    834

    1,002

    Provisions

    59

    49

    63

    Other payables

    920

    802

    879

    Total current liabilities

    2,426

    2,262

    2,328

     

     

     

     

    Non-current liabilities

     

     

     

    Long-term debt and debentures

    2,550

    1,850

    1,909

    Deferred tax liabilities

    477

    500

    481

    Long-term employee liabilities

    365

    330

    331

    Long-term provisions and accruals

    244

    218

    230

    Other

    45

    61

    55

    Total non-current liabilities

    3,681

    2,959

    3,006

     

     

     

     

    Total liabilities

    6,107

    5,221

    5,334

     

     

     

     

    Equity

     

     

     

    Total shareholders' equity

    6,014

    5,746

    5,724

    Non-controlling interests

    254

    238

    263

    Total equity

    6,268

    5,984

    5,987

     

     

     

     

    Total liabilities and equity

    12,375

    11,205

    11,321

    Condensed Consolidated Statements of Cash Flows (Unaudited)

     

    $ millions

    Three-months ended

    Six-months ended

    Year ended

     

    June 30,

    2025

     

    June 30,

    2024

    June 30,

    2025

     

    June 30,

    2024

    December 31,

    2024

    Cash flows from operating activities

     

     

     

     

     

     

     

    Net income

    108

     

     

    130

     

    214

     

     

    256

     

    464

     

    Adjustments for:

     

     

     

     

     

     

     

    Depreciation and amortization

    150

     

     

    152

     

    301

     

     

    299

     

    596

     

    Fixed assets impairment

    -

     

     

    -

     

    -

     

     

    -

     

    14

     

    Exchange rate, interest and derivative, net

    (84

    )

     

    37

     

    (40

    )

     

    96

     

    152

     

    Tax expenses

    60

     

     

    48

     

    102

     

     

    90

     

    172

     

    Change in provisions

    7

     

     

    (11

    )

    2

     

     

    (53

    )

    (50

    )

    Other

    8

     

     

    2

     

    11

     

     

    4

     

    13

     

     

    141

     

     

    228

     

    376

     

     

    436

     

    897

     

     

     

     

     

     

     

     

     

    Change in inventories

    (6

    )

     

    58

     

    22

     

     

    109

     

    (7

    )

    Change in trade receivables

    119

     

     

    26

     

    (83

    )

     

    (115

    )

    26

     

    Change in trade payables

    28

     

     

    (55

    )

    59

     

     

    (29

    )

    104

     

    Change in other receivables

    (4

    )

     

    (14

    )

    (19

    )

     

    4

     

    39

     

    Change in other payables

    (80

    )

     

    (28

    )

    (62

    )

     

    (18

    )

    43

     

    Net change in operating assets and liabilities

    57

     

     

    (13

    )

    (83

    )

     

    (49

    )

    205

     

     

     

     

     

     

     

     

     

    Income taxes paid, net of refund

    (37

    )

     

    (29

    )

    (73

    )

     

    (35

    )

    (98

    )

     

     

     

     

     

     

     

     

    Net cash provided by operating activities

    269

     

     

    316

     

    434

     

     

    608

     

    1,468

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities

     

     

     

     

     

     

     

    Proceeds (payments) from deposits, net

    1

     

     

    11

     

    (3

    )

     

    61

     

    56

     

    Purchases of property, plant and equipment and intangible assets

    (202

    )

     

    (142

    )

    (392

    )

     

    (287

    )

    (713

    )

    Proceeds from divestiture of assets and businesses, net of transaction expenses

    1

     

     

    3

     

    3

     

     

    18

     

    19

     

    Payments from settlement of derivatives, net

    (16

    )

     

    -

     

    (16

    )

     

    -

     

    -

     

    Interest received

    4

     

     

    3

     

    7

     

     

    10

     

    17

     

    Business combinations

    -

     

     

    -

     

    (3

    )

     

    (22

    )

    (74

    )

    Other

    -

     

     

    -

     

    -

     

     

    -

     

    1

     

    Net cash used in investing activities

    (212

    )

     

    (125

    )

    (404

    )

     

    (220

    )

    (694

    )

     

     

     

     

     

     

     

     

    Cash flows from financing activities

     

     

     

     

     

     

     

    Dividends paid to the Company's shareholders

    (55

    )

     

    (59

    )

    (107

    )

     

    (120

    )

    (251

    )

    Receipts of long-term debt

    683

     

     

    140

     

    1,044

     

     

    338

     

    889

     

    Repayments of long-term debt

    (138

    )

     

    (226

    )

    (535

    )

     

    (612

    )

    (1,302

    )

    Repayments of short-term debt

    (206

    )

     

    (18

    )

    (97

    )

     

    (1

    )

    (1

    )

    Interest paid

    (42

    )

     

    (43

    )

    (58

    )

     

    (63

    )

    (122

    )

    Receipts (payments) from transactions in derivatives

    (2

    )

     

    -

     

    (2

    )

     

    3

     

    (2

    )

    Dividend paid to the non-controlling interests

    (42

    )

     

    (57

    )

    (42

    )

     

    (57

    )

    (57

    )

    Net cash provided by (used in) financing activities

    198

     

     

    (263

    )

    203

     

     

    (512

    )

    (846

    )

     

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

    255

     

     

    (72

    )

    233

     

     

    (124

    )

    (72

    )

    Cash and cash equivalents as of the beginning of the period

    312

     

     

    363

     

    327

     

     

    420

     

    420

     

    Net effect of currency translation on cash and cash equivalents

    15

     

     

    (4

    )

    22

     

     

    (9

    )

    (21

    )

    Cash and cash equivalents as of the end of the period

    582

     

     

    287

     

    582

     

     

    287

     

    327

     

    Adjustments to Reported Operating and Net income (non-GAAP)
           
    $ millions

    Three-months ended

     

    Six-months ended

    June 30,

    2025

     

    June 30,

    2024

     

    June 30,

    2025

     

    June 30,

    2024

    Operating income

    181

     

     

    211

     

     

    366

     

     

    414

     

    Charges related to the security situation in Israel (1)

    15

     

     

    14

     

     

    25

     

     

    26

     

    Impairment and write-off of assets and provision for site closure (2)

    5

     

     

    -

     

     

    5

     

     

    -

     

    Fire incident at Ashdod Port (3)

    -

     

     

    -

     

     

    4

     

     

    -

     

    Provision for early retirement (4)

    -

     

     

    -

     

     

    9

     

     

    -

     

    Total adjustments to operating income

    20

     

     

    14

     

     

    43

     

     

    26

     

    Adjusted operating income

    201

     

     

    225

     

     

    409

     

     

    440

     

    Net income attributable to the shareholders of the Company

    93

     

     

    115

     

     

    184

     

     

    224

     

    Total adjustments to operating income

    20

     

     

    14

     

     

    43

     

     

    26

     

    Total tax adjustments (5)

    (3

    )

     

    (3

    )

     

    (7

    )

     

    (6

    )

    Total adjusted net income - shareholders of the Company

    110

     

     

    126

     

     

    220

     

     

    244

     

    (1)

    For 2025 and 2024, reflects charges relating to the ongoing security situation in Israel.

    (2)

    For 2025, reflects a write-off of two portfolio companies due to failed business continuity and funding.

    (3)

    For 2025, reflects expenses related to the fire incident at Ashdod Port.

    (4)

    For 2025, reflects provisions for early retirement due to restructuring at certain sites, as part of the Company's global efficiency plan.

    (5)

    For 2025 and 2024, reflects the tax impact of adjustments made to operating income

    Consolidated EBITDA for the Periods of activity

    $ millions

    Three-months ended

    Six-months ended

     

    June 30,

    2025

     

    June 30,

    2024

    June 30,

    2025

     

    June 30,

    2024

    Net income

    108

     

    130

    214

     

    256

    Financing expenses, net

    13

     

    33

    50

     

    68

    Taxes on income

    60

     

    48

    102

     

    90

    Less: Share in earnings of equity-accounted investees

    -

     

    -

    -

     

    -

    Operating income

    181

     

    211

    366

     

    414

    Depreciation and amortization

    150

     

    152

    301

     

    299

    Adjustments (1)

    20

     

    14

    43

     

    26

    Total adjusted EBITDA

    351

     

    377

    710

     

    739

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" above.

    Calculation of Segment EBITDA

           
    $ millions

    Industrial Products

     

    Potash

     

    Phosphate Solutions (1)

     

    Growing Solutions

     

    Three-months ended

     

    June 30,

    2025

     

    June 30,

    2024

     

    June 30,

    2025

     

    June 30,

    2024

     

    June 30,

    2025

     

    June 30,

    2024

     

    June 30,

    2025

     

    June 30,

    2024

    Segment operating income

    54

     

    60

     

    52

     

    60

     

    90

     

    93

     

    35

     

    25

    Depreciation and amortization

    15

     

    14

     

    63

     

    58

     

    44

     

    53

     

    21

     

    20

    Segment EBITDA

    69

     

    74

     

    115

     

    118

     

    134

     

    146

     

    56

     

    45

    (1)

    For Q2 2025, Phosphate Specialties accounted for $336 million of segment sales, $39 million of operating income, $12 million of D&A and $51 million of EBITDA, while Phosphate Commodities accounted for $301 million of segment sales, $51 million of operating income, $32 million of D&A and represented $83 million of EBITDA.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250805898603/en/

    Investor and Press Contact – Global

    Peggy Reilly Tharp

    VP, Global Investor Relations

    +1-314-983-7665

    [email protected]

    Investor and Press Contact - Israel

    Adi Bajayo

    ICL Spokesperson

    +972-3-6844459

    [email protected]

    Get the next $ICL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ICL

    DatePrice TargetRatingAnalyst
    1/21/2025$4.00 → $6.00Underweight → Equal Weight
    Barclays
    1/12/2024$6.50 → $4.00Overweight → Underweight
    Barclays
    11/14/2023$7.00 → $6.50Equal Weight → Overweight
    Barclays
    5/18/2023Buy → Neutral
    BofA Securities
    6/1/2022$12.00Equal Weight
    Barclays
    2/14/2022$9.00 → $10.00Equal-Weight
    Morgan Stanley
    12/6/2021$7.00 → $9.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ICL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    ICL Group upgraded by Barclays with a new price target

    Barclays upgraded ICL Group from Underweight to Equal Weight and set a new price target of $6.00 from $4.00 previously

    1/21/25 7:50:33 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Group downgraded by Barclays with a new price target

    Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously

    1/12/24 6:56:19 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Group upgraded by Barclays with a new price target

    Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously

    11/14/23 7:37:49 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    SEC Filings

    View All

    SEC Form 6-K filed by ICL Group Ltd.

    6-K - ICL Group Ltd. (0000941221) (Filer)

    8/6/25 6:05:01 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by ICL Group Ltd.

    6-K - ICL Group Ltd. (0000941221) (Filer)

    8/6/25 6:03:45 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by ICL Group Ltd.

    6-K - ICL Group Ltd. (0000941221) (Filer)

    8/6/25 6:01:56 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Israel Corp. Reports Results for Second Quarter of 2025

    TEL AVIV, Israel, Aug. 13, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025. Selected Financial Figures for the Second Quarter 2025: $m Q2/25 Q2/24 ILCO share in ICL profit 40 50 ILCO share in Prodalim profit 2 - Amortization of excess cost in held companies (2) (1) Financing, G&A and other at ILCO headquarter level 2 (1) Tax income of ILCO Headquarters 1 - Net profit to company's shareholders 43 48 Liquidity at the ILCO Headquarters Level[1] As of June 30, 2025, total financial liabilities were $715 million, and investments in liquid assets amounted to $739 million of which $8 million are pled

    8/13/25 12:23:00 PM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Reports Second Quarter 2025 Results

    Sales of $1.8 billion increased year-over-year, with operating income of $181 million, adjusted EBITDA of $351 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2025. Consolidated sales were $1.8 billion, up ~$80 million versus the prior year. Operating income was $181 million versus $211 million of operating income in the second quarter of last year, with adjusted operating income of $201 million versus $225 million. For the second quarter, net income attributable to shareholders was $93 million versus $115 million in the prior year, with adjusted ne

    8/6/25 2:06:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Announces Second Quarter 2025 Earnings Call

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release second quarter 2025 results prior to the opening of the TASE market on Wednesday, August 6, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (289) 819-1520 for international analysts, and the conference ID is 62033. To participate, please dial in a few minutes before the scheduled time.

    7/9/25 4:15:00 PM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Leadership Updates

    Live Leadership Updates

    View All

    ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced its Board of Directors has approved the appointment of Elad Aharonson as ICL's new president and chief executive officer, effective March 13, 2025. He will succeed Raviv Zoller who will work with Aharonson to ensure a smooth and orderly transition. Elad Aharonson has been an integral part of ICL for nearly four years, serving as president of ICL's Growing Solutions business since April of 2021. During his tenure, he led the development of ICL's specialty fertilizer solutions and the expansion of these product offerings into new territories, through both organic efforts and via acquisitions. His signif

    12/23/24 2:10:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Announces Planned Departure of President and CEO Raviv Zoller

    Zoller to continue to serve the company until a replacement has been announced ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Raviv Zoller, the company's president and CEO for the past seven years, is expected to leave the company in early 2025, following both the appointment of a replacement and a formal transition. In a letter to the company's employees, Zoller wrote, "I feel great pride, mixed with sorrow, as I announce my expected retirement from the position as president and CEO of ICL. Over the past seven years at this amazing organization, I have come to know our employees who give their heart and soul to the company. Together, we ha

    12/5/24 7:21:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Recognized by Fortune as a Company That is Changing the World

    Company's Agmatix AI-driven data platform and RegenIQ framework designated as a Friend of Farmers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Agmatix, the company's ag tech digital start-up, has been named to Fortune's 10th Annual Change the World list. The list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Among other factors, nominees are assessed on their measurable impact on people and the planet, profitability related to their impactful work, and the degree of innovation they have demonstrated. Agmatix was recognized for its AI-driven platform, which helps

    10/15/24 4:15:00 PM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Financials

    Live finance-specific insights

    View All

    Israel Corp. Reports Results for Second Quarter of 2025

    TEL AVIV, Israel, Aug. 13, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025. Selected Financial Figures for the Second Quarter 2025: $m Q2/25 Q2/24 ILCO share in ICL profit 40 50 ILCO share in Prodalim profit 2 - Amortization of excess cost in held companies (2) (1) Financing, G&A and other at ILCO headquarter level 2 (1) Tax income of ILCO Headquarters 1 - Net profit to company's shareholders 43 48 Liquidity at the ILCO Headquarters Level[1] As of June 30, 2025, total financial liabilities were $715 million, and investments in liquid assets amounted to $739 million of which $8 million are pled

    8/13/25 12:23:00 PM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Reports Second Quarter 2025 Results

    Sales of $1.8 billion increased year-over-year, with operating income of $181 million, adjusted EBITDA of $351 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2025. Consolidated sales were $1.8 billion, up ~$80 million versus the prior year. Operating income was $181 million versus $211 million of operating income in the second quarter of last year, with adjusted operating income of $201 million versus $225 million. For the second quarter, net income attributable to shareholders was $93 million versus $115 million in the prior year, with adjusted ne

    8/6/25 2:06:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    ICL Announces Second Quarter 2025 Earnings Call

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release second quarter 2025 results prior to the opening of the TASE market on Wednesday, August 6, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (289) 819-1520 for international analysts, and the conference ID is 62033. To participate, please dial in a few minutes before the scheduled time.

    7/9/25 4:15:00 PM ET
    $ICL
    Agricultural Chemicals
    Industrials

    $ICL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ICL Group Ltd.

    SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

    11/14/24 6:11:02 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by ICL Group Ltd.

    SC 13G - ICL Group Ltd. (0000941221) (Subject)

    1/31/24 6:05:59 AM ET
    $ICL
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G/A filed by ICL Group Ltd. (Amendment)

    SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

    1/30/24 8:10:40 AM ET
    $ICL
    Agricultural Chemicals
    Industrials